Delivery Order SPE2DR25D1002-SPE2DR26FGM0S
Award Date 12/29/25
Potential Completion Date 1/21/26
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract valued at $4,027.70. The delivery order, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, represents a competitively awarded non-set-aside procurement. Ingrezza (valbenazine) is an FDA-approved medication used to treat tardive dyskinesia, a neurological condition characterized by...
- The Defense Logistics Agency awarded a delivery order valued at $4,244.58 to AmerisourceBergen Drug Corp for 30 capsules of Ingrezza 80 mg on November 5, 2025, with an ultimate completion date of November 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $4,244.58 to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 6, 2026. Ingrezza (valbenazine) is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Ingrezza 60 mg capsules (30-count units) valued at $4,267.66. This non-competitive delivery order represents a firm fixed price transaction with an ultimate completion date of January 12, 2026. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,748.14 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count package) on November 28, 2025, with completion scheduled for December 19, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Ingrezza 40 mg on September 17, 2025, with completion scheduled for October 8, 2025. This competitive, non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $3,874.06 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units) on November 24, 2025, with completion anticipated by December 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used in the treatment of tardive dyskinesia, a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for Ingrezza 80 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a movement disorder, and represents...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ingrezza 80 mg capsules (quantity 30s). This is a firm fixed price delivery order with an ultimate completion date of October 9, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). The order represents a non-competitive, firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Performance will be completed by December 3, 2025, with fulfillment occurring at the contractor's Conshohocken, Pennsylvania facility. Ingrezza is...